Victory Capital Management Inc Eton Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$3.45 - $4.66 $96,527 - $130,382	27,979 New	27,979 $122,000
Q2 2020 Aug 07, 2020	SELL	$3.5 - $6.09 $8,501 - $14,792	-2,429 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.87 - $7.47 $815 - $2,121	284 Added 13.24%	2,429 $10,000
Q4 2019 Feb 04, 2020	BUY	$5.59 - $7.2 $100 - $129	18 Added 0.85%	2,145 $14,000
Q3 2019 Nov 12, 2019	BUY	$5.19 - $8.72 $11,039 - $18,547	2,127 New	2,127 $13,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $264M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.